Stock Events

Stock Events

CS Diagnostics 

$0.007300
1
+$0.01+1,725%Tuesday 20:00

Statistics

Day High
0.07
Day Low
0.07
52W High
0.4
52W Low
0.0004
Volume
100
Avg. Volume
3,884
Mkt Cap
1.82M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Financials

34.8%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
204,000Revenue
71,000Net Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap257.71B
Thermo Fisher Scientific offers a wide range of diagnostic and research tools, directly competing in the laboratory equipment and diagnostics market.
Danaher
DHR
Mkt Cap163.25B
Danaher Corporation operates in the life sciences and diagnostics sectors, providing similar diagnostic solutions and technologies.
Illumina
ILMN
Mkt Cap41.23B
Illumina, Inc. specializes in genomic sequencing tools and technologies, competing in the diagnostics field particularly in genetic analysis.
Bio-Rad Laboratories
BIO
Mkt Cap9.87B
Bio-Rad Laboratories provides instruments and consumables in the field of clinical diagnostics, directly competing with CS Diagnostics in the healthcare diagnostics market.
Agilent Technologies
A
Mkt Cap47.3B
Agilent Technologies provides instruments, services, and consumables in the diagnostics and research field, overlapping with CS Diagnostics' market.
Qiagen NV
QGEN
Mkt Cap9.24B
QIAGEN offers sample and assay technologies for molecular diagnostics, applied testing, and academic research, competing in the diagnostics market.
Guardant Health
GH
Mkt Cap23.86B
Guardant Health specializes in oncology-based diagnostics, including liquid biopsies, which is a growing area of competition in the diagnostics sector.
Fulgent Genetics
FLGT
Mkt Cap591.03M
Fulgent Genetics offers genetic testing to provide comprehensive reports, competing in the genetic diagnostics space similar to CS Diagnostics.

About

Headquartered in Neuss, Germany, CS Diagnostics Corp. was established in 1996. The company is dedicated to the development, production, and worldwide distribution of a range of health and medical-grade products, catering to both domestic German and international markets. Among its key offerings are MEDUSA, an exclusive surface disinfectant, and CS-Protect Hydrogel, a specialized tissue-spacing gel for radiation therapy applications. The firm rebranded as CS Diagnostics Corp. in August 2023, having previously operated under the name FlashZero Corp.
Show More
CEO
Thomas Fahrhoefer
Employees
1
Country
United States
ISIN
US33852L2025

Listings

OTC Link
US
CSDX

0 Comments

Share your thoughts

FAQs

What is CS Diagnostics stock price today?▼
The current price of CSDX is $0.01 USD — it has increased by +1,725% in the past 24 hours. Watch CS Diagnostics stock price performance more closely on the chart.
What is CS Diagnostics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange CS Diagnostics stocks are traded under the ticker CSDX.
Is CS Diagnostics stock price growing?▼
CSDX stock has risen by +0% compared to the previous week, the month change is a -14.12% fall, over the last year CS Diagnostics has showed a -97.97% decrease.
What is CS Diagnostics market cap?▼
Today CS Diagnostics has the market capitalization of 1.82M
What is CS Diagnostics revenue for the last year?▼
CS Diagnostics revenue for the last year amounts to 204,000 USD.
What is CS Diagnostics net income for the last year?▼
CSDX net income for the last year is 71,000 USD.
How many employees does CS Diagnostics have?▼
As of November 2, 2026, the company has 1 employees.
In which sector is CS Diagnostics located?▼
CS Diagnostics operates in the Health & Wellness sector.
When did CS Diagnostics complete a stock split?▼
The last stock split for CS Diagnostics was on August 3, 2023 with a ratio of 1:100000.
Where is CS Diagnostics headquartered?▼
CS Diagnostics is headquartered in Cheyenne, United States.